Mode
Text Size
Log in / Sign up
Phase 2 N=8 Randomized Triple-blind Treatment

Botulinum Toxin for the Management of Chronic Orchialgia

Chronic Testicular Pain

Enrolled (actual)
8
Serious AEs
0.0%
Results posted
Jan 2018
Primary outcome: Primary: Visual Analog Scale for Pain Score — 59.3; 30.3; 55.0; 75.0 units on a scale

Study Design & Population

Study type
Interventional
Phase
Phase 2
Interventions
Botox Injection (Drug); Normal saline injection (Procedure)
Age
Pediatric, Adult, Older Adult
Sex
Male
Sponsor
Wake Forest University Health Sciences
Primary completion
Oct 2016

Outcome Measures

OutcomeResultp-value
PRIMARY
Visual Analog Scale for Pain Score
59.3; 30.3; 78.7; 61
PRIMARY
Visual Analog Scale for Pain Score
59.3; 30.3; 78.7; 61
PRIMARY
Visual Analog Scale for Pain Score
59.3; 30.3; 78.7; 61
PRIMARY
Visual Analog Scale for Pain Score
59.3; 30.3; 78.7; 61
PRIMARY
Quality of Life Questionnaire Score
77.04; 86.59
PRIMARY
Quality of Life Questionnaire Score
77.04; 86.59
PRIMARY
Quality of Life Questionnaire Score
77.04; 86.59
PRIMARY
Quality of Life Questionnaire Score
77.04; 86.59
PRIMARY
Units of Analgesics Used for Testicular Pain
3.3; 2.5; 0; 2.5
PRIMARY
Units of Analgesics Used for Testicular Pain
3.3; 2.5; 0; 2.5
PRIMARY
Units of Analgesics Used for Testicular Pain
3.3; 2.5; 0; 2.5
PRIMARY
Units of Analgesics Used for Testicular Pain
3.3; 2.5; 0; 2.5

Summary

The purpose of this research study is to determine if Botox injections will provide relief from chronic testicular pain. In the study, the spermatic cord of particpants will be injected with either Botox or a placebo of saline. Botox is currently used to treat other urological conditions like overactive bladder and lower urinary tract problems. For these conditions, Botox works by relaxing muscles in the affected areas. The investigators believe that Botox will act similarly in the treatment chronic testicular pain.

Eligibility Criteria

Inclusion Criteria

  • Clinical diagnosis of chronic testicular pain (orchialgia)

Exclusion Criteria

  • Active infection of urinary tract (UTI)
  • Active infection of the scrotal skin of the affected side
  • Bilateral orchiectomy
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02058836). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search